[Form 3] NOVA LTD. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Nova Ltd. director Oppenhaim Eitan filed a Form 3 as an initial statement of beneficial ownership of the company’s ordinary shares. The filing lists several direct holdings, with individual blocks including 3,008 ordinary shares, 2,586 ordinary shares, 1,932 ordinary shares, and 646 ordinary shares.
Footnotes clarify that these positions represent ordinary shares issuable upon vesting and settlement of restricted share units granted on May 18, 2023, June 20, 2024, and June 18, 2025. The 2023 and 2024 grants vest 25% on each anniversary of the grant date, while the 2025 grant vests 100% on the first anniversary. The document records existing equity awards rather than new open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Oppenhaim Eitan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 646 shares (Direct)
Footnotes (1)
- Represents ordinary shares issuable upon vesting and settlement of an equivalent number of restricted share units (RSUs) granted to the Reporting Person by the Issuer on May 18, 2023, which vest in accordance with the following schedule: 25% of the RSUs will vest upon each anniversary of the grant date. Represents ordinary shares issuable upon vesting and settlement of an equivalent number of restricted share units (RSUs) granted to the Reporting Person by the Issuer on June 20, 2024, which vest in accordance with the following schedule: 25% of the RSUs will vest upon each anniversary of the grant date. Represents ordinary shares issuable upon vesting and settlement of an equivalent number of restricted share units (RSUs) granted to the Reporting Person by the Issuer on June 18, 2025, which vest in accordance with the following schedule: 100% of the RSUs will vest on the first anniversary of the grant date.
FAQ
What does Nova (NVMI) director Oppenhaim Eitan’s Form 3 report?
The Form 3 reports Oppenhaim Eitan’s initial beneficial ownership of Nova ordinary shares. It lists several direct holdings in ordinary shares that mainly reflect restricted share unit grants and their associated vesting schedules rather than new open‑market transactions.
Are there any buy or sell transactions in Nova (NVMI) director’s Form 3?
The Form 3 does not show explicit buy or sell transactions. All entries are categorized as holdings, with unknown transaction codes and no share amounts reported as purchased or sold, indicating disclosure of existing awards rather than trading activity.
What are the vesting terms for Nova (NVMI) RSUs granted to Oppenhaim Eitan?
The RSUs granted in 2023 and 2024 vest 25% on each anniversary of the grant date. The RSUs granted on June 18, 2025 vest 100% on the first anniversary, creating a mix of multi‑year and one‑year vesting schedules for these awards.
Which grant dates are referenced in Nova (NVMI) director’s RSU footnotes?
The footnotes reference RSU grants on May 18, 2023, June 20, 2024, and June 18, 2025. Each grant converts into ordinary shares upon vesting and settlement, with specific vesting schedules tied to these individual grant dates.